(5α)-3-(Acetyloxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-[[[[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]amino]carbonyl]oxy]-morphinan-6-one is an intermediate used in the synthesis of Naldemedine (N232550), which is a peripherally selective mu opioid receptor antagonist used in the treatment in pain.
